In addition, inhibition of LMP1 expression by siRNA may be a good prospect; LPM1 siRNA has been shown to induce cell cycle arrest and enhance sensitivity to cisplatin in an EBV-positive NPC derived cell line [49]. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.